-
-
-
-
-
-
-
Rain Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Rain Oncology to Report Fourth Quarter and Full Year 2022 Financial Results and Highlights of Recent Progress on March 9, 2023
-
-
-
-
-
-
-
Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma
-
-
-
-
-
-
-
Rain Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Progress
-
-
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

